JP6919119B2 - ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 - Google Patents

３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 Download PDF

Info

Publication number
JP6919119B2
JP6919119B2 JP2018009249A JP2018009249A JP6919119B2 JP 6919119 B2 JP6919119 B2 JP 6919119B2 JP 2018009249 A JP2018009249 A JP 2018009249A JP 2018009249 A JP2018009249 A JP 2018009249A JP 6919119 B2 JP6919119 B2 JP 6919119B2
Authority
JP
Japan
Prior art keywords
tablet
per tablet
hpc
prototype
solid preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018009249A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018118966A5 (enExample
JP2018118966A (ja
Inventor
吉田圭一
小松倫士
土屋雅彦
池田絵理
大橋真生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NISSIN PHARMACEUTICAL CO., LTD.
Original Assignee
NISSIN PHARMACEUTICAL CO., LTD.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NISSIN PHARMACEUTICAL CO., LTD. filed Critical NISSIN PHARMACEUTICAL CO., LTD.
Publication of JP2018118966A publication Critical patent/JP2018118966A/ja
Publication of JP2018118966A5 publication Critical patent/JP2018118966A5/ja
Application granted granted Critical
Publication of JP6919119B2 publication Critical patent/JP6919119B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2018009249A 2017-01-23 2018-01-23 ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 Active JP6919119B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017009736 2017-01-23
JP2017009736 2017-01-23

Publications (3)

Publication Number Publication Date
JP2018118966A JP2018118966A (ja) 2018-08-02
JP2018118966A5 JP2018118966A5 (enExample) 2021-06-10
JP6919119B2 true JP6919119B2 (ja) 2021-08-18

Family

ID=63043564

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018009249A Active JP6919119B2 (ja) 2017-01-23 2018-01-23 ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。

Country Status (1)

Country Link
JP (1) JP6919119B2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019146642A1 (ja) * 2018-01-24 2019-08-01 大原薬品工業株式会社 γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法
JP6504638B1 (ja) * 2018-05-31 2019-04-24 武田テバファーマ株式会社 錠剤及びその製造方法
WO2019244649A1 (ja) 2018-06-22 2019-12-26 ソニー株式会社 描画および消去装置ならびに消去方法
WO2022168968A1 (ja) * 2021-02-05 2022-08-11 学校法人近畿大学 末梢神経障害の予防又は改善剤
CN115340427B (zh) * 2022-03-10 2023-04-11 南开大学 一种赤铁矿-羧甲基纤维素-营养盐复合物及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1077692T3 (da) * 1998-05-15 2004-12-06 Warner Lambert Co Aminosyrestabiliserede gabapentin- og pregabalinpræparater og fremgangsmåder til fremstilling deraf
HU228772B1 (en) * 1998-05-15 2013-05-28 Warner Lambert Co Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
BRPI0614021A2 (pt) * 2005-01-21 2011-03-01 Pharmanova Inc formulações farmacêuticas e métodos de uso
NL2000281C2 (nl) * 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
DE102007019071A1 (de) * 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
US8454993B2 (en) * 2007-11-23 2013-06-04 Lupin Limited Controlled release pharmaceutical compositions of pregabalin
TR200909613A1 (tr) * 2009-12-22 2011-07-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Pregabalinin farmasötik bileşimleri.
WO2011104652A2 (en) * 2010-02-24 2011-09-01 Pfizer Inc. Veterinary compositions
HU230031B1 (hu) * 2010-03-01 2015-05-28 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
EP2415460A1 (de) * 2010-08-03 2012-02-08 ratiopharm GmbH Orale Darreichungsform von Pregabalin
KR101724024B1 (ko) * 2011-07-26 2017-04-06 주식회사유한양행 2상 방출-제어 시스템에 의한 프레가발린을 함유하는 서방성 정제
CN103385870A (zh) * 2012-05-09 2013-11-13 鲁南制药集团股份有限公司 普瑞巴林的医药用途
GB201301242D0 (en) * 2013-01-24 2013-03-06 Hofmeyr Phillip R Tennis teaching aids
EP2826470B1 (en) * 2013-07-19 2017-09-06 Arven Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of pregabalin
IN2014MU00215A (enExample) * 2014-01-22 2015-08-28 Intas Pharmaceuticals Ltd
CN104906064B (zh) * 2015-05-15 2017-12-22 中国药科大学 一种普瑞巴林胃漂浮缓释片剂及其制备方法
CN108478537A (zh) * 2018-05-03 2018-09-04 南京易亨制药有限公司 一种含普瑞巴林的单室渗透泵控释片剂

Also Published As

Publication number Publication date
JP2018118966A (ja) 2018-08-02

Similar Documents

Publication Publication Date Title
JP6092936B2 (ja) 口腔内崩壊錠の製造方法
EP2646003B1 (en) Rapidly dispersing granules, orally disintegrating tablets and methods
JP4989733B2 (ja) 口腔内崩壊錠
JP6919119B2 (ja) ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
EP3398588A1 (en) Compression-molded preparation
JP2017141299A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2019019113A (ja) メマンチン塩酸塩含有口腔内崩壊錠
TW201217001A (en) Particle coating preparation
JP5978335B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP7148319B2 (ja) プラスグレルを含む口腔内崩壊錠
WO2010119851A1 (ja) 口腔内崩壊錠
WO2019098327A1 (ja) 速溶性薬物の苦味が抑制された口腔内崩壊錠
JP7023186B2 (ja) 認知症治療薬を含有する口腔内崩壊性錠剤
EP3251661B1 (en) Raloxifene sprinkle composition
JP6151413B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP5714652B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP7308022B2 (ja) 速溶性薬物の苦味が抑制された口腔内崩壊錠
JP6855387B2 (ja) 圧縮成型製剤
JP6150564B2 (ja) 口腔内速崩壊性錠剤
JP2005194225A (ja) 胃内崩壊性錠剤
JP2019203031A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20201006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210121

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210121

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20210123

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20210208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210423

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210519

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210611

R150 Certificate of patent or registration of utility model

Ref document number: 6919119

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D04